Overview
Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis
Status:
Terminated
Terminated
Trial end date:
2019-12-31
2019-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of Central FloridaTreatments:
Sodium thiosulfate
Criteria
Inclusion Criteria:- Male or female adult 18 years of age or older
- Must have health insurance will be eligible to participate
- Must have a current diagnosis of dystrophic or idiopathic calcinosis cutis
- Subjects must have at least 2 lesions of at least 2mm in size
Exclusion Criteria:
- Unable to read and speak English
- Allergy to any component of the sodium thiosulfate solution
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Women who are breastfeeding
- Prisoners